Open an account

Shoulder Innovations

SI · NYSE

$18.72+$0.47 (+2.58%)TodayMarket closed ·
Prev close $18.25

About SI

Shoulder Innovations, Inc. manufactures medical devices. The company is headquartered in Grand Rapids, Michigan and currently employs 72 full-time employees. The company went IPO on 2025-07-31. The firm offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.

Employees
74
Headquarters
Grand Rapids, Michigan
Listed
Jul 31, 2025
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
shoulderinnovations.com

SI key statistics

Market cap
389.73M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
106.84K
Volume
67.59K
Open price
$18.53
High today
$19.03
Low today
$18.30
52 Week high
$24.60
52 Week low
$10.92

Shoulder Innovations (SI) at a glance

As of Oct 20, 2026, Shoulder Innovations (SI) shares are priced at $18.72, giving the company a market cap of 389.73M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $18.30 and $19.03. The current price is 2.3% above the day's low and 1.6% below its high.

Volume so far is 67.59K shares, below the average of 106.84K shares a day.

Over the past year Shoulder Innovations has ranged from $10.92 to $24.60, and now sits 57% of the way up that range.

Shoulder Innovations met or beat analyst EPS estimates in 3 of the last 5 quarters. In Q2 FY26 it reported -$0.46 per share against an estimate of -$0.4735.

The average analyst price target is $26.77, 43.0% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 4 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 7 analystsAvg $26.77
Low
$25.25
Now
$18.72
High
$29.40

SI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 5 quarters, by 32.5% on average.

  1. Q2 FY25: reported -$0.06 per share against an estimate of -$0.7107
  2. Q3 FY25: reported -$0.64 per share against an estimate of -$0.3172
  3. Q4 FY25: reported -$0.38 per share against an estimate of -$0.3319
  4. Q1 FY26: reported -$0.41 per share against an estimate of -$0.4231
  5. Q2 FY26: reported -$0.46 per share against an estimate of -$0.4735

SI news

  • Press releasePRNewswire

    Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026

  • Transcript: Shoulder Innovations Q2 2026 Earnings Conference Call

  • Press releasePRNewswire

    Shoulder Innovations Initiates Commercial Launch of the InSet® Go

  • Press releasePRNewswire

    Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch

  • Press releasePRNewswire

    Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures

  • Press releasePRNewswire

    Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience

  • Press releasePRNewswire

    Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

  • Press releasePRNewswire

    Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Similar companies

Companies in the same industry as Shoulder Innovations

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.